ArticleMalariaWorld journal2018
End malaria for good: a review of current strategies and future novelties for malaria elimination in Nigeria.
Article in MalariaWorld journal, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- Wavelet analysis and time series forecasting of malaria incidence across different transmission settings in Nigeria.BMC infectious diseases · 2026Article
- Knowledge of malaria diagnosis and prevention linking awareness of low transmission to eradication efforts.Scientific reports · 2025Article
- Eliminating malaria in Nigeria: insights from Egypt's success and pathways to sustainable eradication.Malaria journal · 2025Review
- Examining the paradox: increased malaria risk in children under 5 in female-headed households in Nigeria.Malaria journal · 2024Article
- A snapshot of the prevalence of dihydropteroate synthase-431V mutation and other sulfadoxine-pyrimethamine resistance markers in Plasmodium falciparum isolates in Nigeria.Malaria journal · 2023Article
- Issues related to the approval of the R21/Matrix-M malaria vaccine for use in Nigeria and Ghana.Frontiers in public health · 2023Article
- Nigeria End Malaria Council: What to expect.Annals of medicine and surgery (2012) · 2022Article
- Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers.Annals of medicine and surgery (2012) · 2022Article
- Impact of climatic variables on childhood severe malaria in a tertiary health facility in northern Nigeria.Sudanese journal of paediatrics · 2021Article
- Malaria Prevention Measures among Pregnant Women: A Population-Based Survey in Nnewi, Nigeria.TheScientificWorldJournal · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Malaria is endemic in 91 countries and territories. Currently, over half of the world's population is at risk for malaria with malaria prevalence in sub-Saharan Africa remaining the highest in the world. Nigeria accounts for 56% of malaria cases in the West African sub-region. Malaria control is historically the oldest control programme in Nigeria, having been in existence since 1948. Malaria control in Nigeria is guided by National Malaria Strategic Plans. The goal of the NMSP (2014-2020) is 'to reduce malaria burden to pre-elimination levels and bring malaria-related mortality to zero' using strategies under seven strategic objectives. The theme for the 2017 World Malaria Day activities was 'End Malaria for Good'. This theme indicates a sustained push for national and international commitments toward goal zero. Although the prevalence of malaria has dropped significantly, from 42% in 2010 to 27.4% in 2015, a lot of effort needs to be made to actualise a malaria-free Nigeria. This review discusses the current strategies in place to control and eliminate malaria. It also describes some future novelties available to sub-Saharan Africa and Nigeria to 'End Malaria for Good.'
Identifiers
34532244PMC8415072What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.